ArticleFrontiers in oncology2022

Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm, Prospective, Open-Label, Phase II Clinical Trial (TR-EAT).

Lei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.